Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Shares lifted to record highs by lockdown easing, benign Fed

Thu, 08th Apr 2021 10:52

* Europe's STOXX index up 0.3%

* S&P futures reach another peak, Nikkei lags

* Asian stock markets : https://tmsnrt.rs/2zpUAr4

* Fed sticking to stimulus, Powell set to speak

* Treasury yields dip, leaving dollar aimless

By Huw Jones

LONDON, April 8 (Reuters) - Stocks in Europe reached record
highs on Thursday, buoyed by optimism in Britain over easing
lockdown restrictions, while a benign outlook for U.S. interest
rates was set to push Wall Street to new heights.

The European STOXX index of leading 600 companies
rose 0.3%, hitting a new high of 436.66 points. London's blue
chip FTSE 100 index was up 0.2%.

"It's looking good as evaluations in Europe are much lower
than they are in the U.S. so there is potentially more upside.
The line of least resistance for European markets is higher,"
said Michael Hewson, chief market analyst at CMC Markets.

"In terms of economic re-opening, there is enough optimism
built in at the moment to drive markets quite a bit higher from
here, and the Fed has reiterated it's going to remain on hold
for a while," Hewson said.

Minutes of the Federal Reserve's last policy meeting,
published on Wednesday, showed members felt the economy was
still far short of target and were in no rush to scale back
their $120 billion a month of bond buying.

Fed Chairman Jerome Powell speaks at an International
Monetary Fund event later on Thursday and is likely to reiterate
the dovish outlook.

The European Central Bank was due to publish accounts for
its March 11 policy meeting amid debate about when it should
start tapering its pandemic stimulus, with the euro area
recovery still in doubt.

Wall Street was also set to reach fresh peaks on Thursday
with e-mini futures on the S&P 500 rising 0.25% after
rising to a record high, and Nasdaq futures up 0.7%

Gains by U.S. Treasuries also helped, although
analysts said markets will be tested next week when the U.S.
earnings seasons gets underway.

In Asia, MSCI's broadest index of Asia-Pacific shares
outside Japan inched up 0.3% in quiet trade.
Japan's Nikkei slipped 0.3%, not helped by news Tokyo's
governor had asked for emergency measures to stem a surge of
COVID-19 infections.

Yields on 10-year Treasuries have eased back
to 1.669% from the recent 14-month high of 1.776%, but have
struggled to break under 1.59%.

The decline coincided with a dip in the dollar index to
92.360 from its recent five-month high at 93.439.

The euro was steady at $1.1871, after rising as high
as $1.1914 overnight following a surprisingly upbeat survey of
European Union business activity.

In commodity markets, gold was at $1,743 an ounce
after meeting resistance around $1,745.

Oil prices fell after official figures showed a big
increase in U.S. gasoline stockpiles, causing concerns about
demand for crude weakening in the world's biggest consumer of
the resource at a time when supplies around the world are
rising.

Brent fell 22 cents to $62.94 a barrel. U.S. crude
lost 37 cents to $59.40 per barrel.

(Aditional reporting by Wayne Cole and Chibuike Oguh; editing
by Larry King)

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.